5431-37-8Relevant articles and documents
Graphene-oxide/schiff base N2O4 ligand-palladium: A new catalyst for the synthesis of furan derivatives
Noori, Samira,Ghorbani-Vaghei, Ramin,Azadbakht, Reza,Karamshahi, Zahra,Koolivand, Mostafa
, (2021/11/17)
In this paper, we aimed at synthesizing GO/H2L-Pd nano-composites (graphene-oxide/schiff base N2O4 Ligand-palladium) as a new heterogeneous catalyst. Different analytical techniques were applied in order to analyze the chemical composition and the structure of the catalyst. The findings revealed that GO/H2L-Pd could catalyze synthesis of furan derivatives in one-pot three-component condensation reaction by different aromatic aldehydes, arylamine and acetylenedicarboxylate. The major advantages of this study are the green and mild procedure, easy reaction work-up, short reaction time, high yields, and reusability of the catalyst.
Synthetic and structural investigations of bis(N -alkyl-benzoselenadiazolium) cations
Lee, Lucia Myongwon,Corless, Victoria,Luu, Helen,He, Allan,Jenkins, Hilary,Britten, James F.,Adam Pani, Faisal,Vargas-Baca, Ignacio
, p. 12541 - 12548 (2019/08/26)
The synthesis, and spectroscopic and structural characterization of bridged dicationic derivatives of benzo-2,1,3-selenadiazoles are reported. The chloride salt of [H4C6NSeN-CH2-CH2-NSeNC6H4/sub
1,4-Diarylpiperazines and analogs as anti-tubercular agents: Synthesis and biological evaluation
Forge,Cappoen,Laurent,Stanicki,Mayence,Huang,Verschaeve,Huygen,Vanden Eynde
scheme or table, p. 95 - 101 (2012/04/10)
Despite progress in modern chemotherapy to combat tuberculosis, the causative pathogen Mycobacterium tuberculosis (M.tb.) is far from eradicated. Bacillary resistance to anti-mycobacterial agents, bacillary persistence and human immunodeficiency virus (HIV) co-infection hamper current drug treatment to completely cure the infection, generating a constant demand for novel drug candidates to tackle these problems. A small library of novel heterocyclic compounds was screened in a rapid luminometric in vitro assay against the laboratory M.tb. strain H37Rv. A group of amidines was found to have the highest potency and was further evaluated for acute toxicity against C3A hepatocytes. Next, the most promising compounds were evaluated for activity against a multi-drug resistant clinical isolate. The group of amidines was also tested for their ability to kill intracellular M.tb. residing in mouse J774A.1 macrophages. Finally, we report on a correlation between the structural differences of the compounds and their anti-mycobacterial activity.